StockClub

KRYS

KRYSKrystal Biotech, Inc.$ --
Krystal Biotech, Inc.

Krystal Biotech, Inc.

KRYS

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
116M USD
YoY +31.9%
Operating Income
54M USD
YoY +48.4%
Net Income
56M USD
YoY +56.5%
EPS
1.91$
YoY +54.0%

Revenue

$116.4M
FY2024 Q2$115.5M
$115.5M
Q2
FY2024 Q3$199.4M
$199.4M
Q3
FY2024 Q4$290.5M
$290.5M
Q4
FY2025 Q1$88.2M
$88.2M
Q1
FY2025 Q2$184.2M
$184.2M
Q2
FY2025 Q3$282M
$282M
Q3
FY2025 Q4$389.1M
$389.1M
Q4
FY2026 Q1$116.4M
$116.4M
Q1
Actual
+$28.2M (+31.9%)

Net Income

$55.9M
FY2024 Q2$16.5M
$16.5M
Q2
FY2024 Q3$43.7M
$43.7M
Q3
FY2024 Q4$89.2M
$89.2M
Q4
FY2025 Q1$35.7M
$35.7M
Q1
FY2025 Q2$74.1M
$74.1M
Q2
FY2025 Q3$153.4M
$153.4M
Q3
FY2025 Q4$204.8M
$204.8M
Q4
FY2026 Q1$55.9M
$55.9M
Q1
Actual
+$20.2M (+56.5%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$0
FY2022
$0
FY2023MISS
Actual:$50.7M
Est:$166.2M
FY2023MISS
$50.7M
FY2024BEAT
Actual:$290.5M
Est:$289.9M
FY2024BEAT
$290.5M
FY2025BEAT
Actual:$389.1M
Est:$387.6M
FY2025BEAT
$389.1M

Analyst Estimates